Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.02
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
5.01
-0.01 (-0.30%)
After-hours: Dec 5, 2025, 4:10 PM EST
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $120.84 million as of December 5, 2025. Its market cap has increased by 116.98% in one year.
Market Cap
120.84M
Enterprise Value
105.10M
1-Year Change
116.98%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $120.84M, a decrease of -85.87%. That is a compound annual growth rate of -25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 120.84M | 313.46% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | 437.69M | -37.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |